Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders
収録刊行物
-
- Critical Reviews in Oncology/Hematology
-
Critical Reviews in Oncology/Hematology 122 202-207, 2018-02
Elsevier BV